Physician profile
Christopher Payne
NPI 1558363507
$2,547.67
in general payments reported to CMS, 2019-2025
30 companies · $388 in 2025
The $388 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $72.26 · 2021: $113 · 2022: $223 · 2023: $553 · 2024: $601 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,542.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $370.70 | 2019-2025 | |
| Astellas Pharma US INC | $362.67 | 2019-2025 | Myrbetriq, Veozah, Xtandi |
| Sumitomo Pharma America, INC. | $233.73 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $196.49 | 2019-2025 | Rezum Generator, General - Female Sui |
| Axonics, INC. | $157.90 | 2021-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $145.87 | 2021-2025 | Aquabeam System, Aquabeam Robotic System |
| Pfizer INC. | $116.53 | 2023-2025 | |
| Teleflex LLC | $107.43 | 2023-2024 | Urolift |
| Urovant Sciences INC | $89.75 | 2022 | |
| Neotract INC. | $82.72 | 2019-2020 | |
| 180 Medical, INC. | $70.28 | 2023-2024 | Self-Cath |
| Ferring Pharmaceuticals INC. | $68.34 | 2019-2024 | Adstiladrin |
| Endo USA, INC. | $57.23 | 2024-2025 | Aveed, Xiaflex |
| Glaxosmithkline, LLC. | $53.31 | 2019 | |
| Urogen Pharma, INC. | $48.41 | 2021-2024 | Jelmyto |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $41.20 | 2019-2023 | |
| Verity Pharmaceuticals INC. | $41.15 | 2025 | Tlando, Trelstar |
| Accord Healthcare, INC. | $40.20 | 2022-2023 | |
| Medtronic, INC. | $39.86 | 2022-2024 | Interstim |
| Dendreon Pharmaceuticals LLC | $34.32 | 2025 | Provenge |
| Allergan, INC. | $29.25 | 2021 | |
| Antares Pharma, INC. | $23.21 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.25 | 2019 | |
| Ambu INC. | $19.63 | 2024 | |
| Myovant Sciences INC. | $18.57 | 2021 | |
| Siemens Medical Solutions USA, INC. | $17.51 | 2019 | |
| Cook Medical LLC | $15.11 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $14.84 | 2019 | |
| Laborie Medical Technologies Corp. | $14.76 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Tolmar, INC. | $14.45 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.